Schneiderman Daniel H
SEC insider (Form 3/4/5 filer). CIK 0001565536. Chief Financial Officer at Pasithea Therapeutics Corp. (KTTA). 3 reported Form 4/5 transactions since Sep 2024; latest on May 1, 2026. Located in MIAMI BEACH, FL.
Companies Schneiderman Daniel H has filed insider reports for
- Pasithea Therapeutics Corp. (KTTA): Officer, Chief Financial Officer
Schneiderman Daniel H
CIK: 0001565536
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KTTA
Pasithea Therapeutics Corp.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- May 1, 2026KTTA
Pasithea Therapeutics Corp.
AwardDirectStock Option (right to buy)
1.1M shares- - Nov 28, 2025KTTA
Pasithea Therapeutics Corp.
AwardDirect26.7K shares at avg. $0.75$20K - Oct 24, 2025KTTA
Pasithea Therapeutics Corp.
AwardDirectStock Option (right to buy)
317.3K shares-
1-3 of 3 transactions